What are some of the undervalue stocks at the moment?

Ray Delera · Jul 31, 2021

ECOR and ARDX way under valued right now. Im surprised no one is talking about ARDX specially after last week.

vanzandt · Nov 16, 2022

This stock was halted today pending an FDA advisory board recommendation.
Kidney drug.
It's $1.23 on the ask and I think it comes off the halt at 5PM EST.
They got the nod.
If it doesn't open until tomorrow, might be worth a look pre-market.

ARDX

Nov 16 (Reuters) - A panel of advisers to the U.S. Food and Drug Administration on Wednesday recommended the approval of Ardelyx Inc's(ARDX) drug for chronic kidney disease patients on dialysis.
The panel voted in favor of the drug both as a single therapy for treating high phosphate levels in the blood of chronic kidney disease patients on dialysis as well as alongside existing treatment. (Reporting by Khushi Mandowara and Leroy Leo; Editing by Krishna Chandra Eluri)

vanzandt · Nov 16, 2022

It just opened at 7PM. $1.90
About 500K shares have traded. Everyone has gone home.
$2 on the ask.
Buy at your own risk, but I think it goes higher tomorrow.
It was $8 in 2021.

*note: This is not a final approval. It still has to complete Phase 3.
If approved, Piper Sandler sees $800 million in sales potential within five years of launch for Ardelyx. Total revenue to date for the company is only about $8M for perspective.

Here's a Seeking Alpha article from last month.
https://seekingalpha.com/article/45...growth-must-strengthen-its-financial-position

$2.12 on the ask now.

vanzandt · Dec 30, 2022

vanzandt said:
This stock was halted today pending an FDA advisory board recommendation.
Kidney drug.
It's $1.23 on the ask and I think it comes off the halt at 5PM EST.
They got the nod.
If it doesn't open until tomorrow, might be worth a look pre-market.

ARDX

Nov 16 (Reuters) - A panel of advisers to the U.S. Food and Drug Administration on Wednesday recommended the approval of Ardelyx Inc's(ARDX) drug for chronic kidney disease patients on dialysis.
The panel voted in favor of the drug both as a single therapy for treating high phosphate levels in the blood of chronic kidney disease patients on dialysis as well as alongside existing treatment. (Reporting by Khushi Mandowara and Leroy Leo; Editing by Krishna Chandra Eluri)

$2.80 now.
100%+ good enough for ya'll?

murray t turtle · Jan 4, 2023

longandshort said:
"Undervalued" is a very ambiguous term. But I'll help you understand value from a professionals point of view:
- The value factor explains the returns of stocks that have low pe/, p/b, ev/ebitda ratios (usually lowest quintile rank, e.g. bottom 20%)
- These stocks tend to perform better during periods of recovery or rising interest rates because they typically have higher free cash flows (or are economically depressed)
- They will underperform growth stocks assuming low rates (sub 3% on the 10-yr)

Trading these companies is not a great strategy.

A better strategy is to find value gaps. For example, say XYZ Corp is trading at 34x forward PE (consensus). Recently, however, the industry began to experience significant (and accelerating) growth. Using your estimate of the company, you find that at current prices, the stock is trading at 22x forward PE. The market is not assigning a high enough probability to your growth forecast and this may represent a good value. Your due diligence will prove or disprove your thesis (of a value gap) -- maybe the company has pending litigation, or perhaps the CEO has hinted she will retire; you will need to evaluate that catalysts to determine if they are likely and what their impact on the bottom line will be (also, how will the market react to positive/negative news on those?).

Buying "value" is a quality, not quantity, style of investing/trading.

%%\
EXACTLY\ so called value stocks tend to underperform i prefer a hi + higher PE\
+ above 200dma . ALL insurance co is upticking, terrible EPS, so buyer beware\maybe.
WOW, Watchdog on Wall Street [ radio like Dave ramsey]went back in time tunnel so to speak\ + noted JP Morgan [banker, not the bank/LOL] said ''during a bear market stocks return to thier rightful owners[managers]''
Not sure his point when he quoted for CAT 'N HAT kids book ;
stalking CAT stock for several days, i already have my DEER for the year. NOT a stock tip\educational post only :caution:

Sergio123 · Jan 16, 2023

Energy pipelines, homebuilders, and steel companies look undervalued based on P/E and dividends.

vanzandt · Oct 18, 2023

vanzandt said:
This stock was halted today pending an FDA advisory board recommendation.
Kidney drug.
It's $1.23 on the ask and I think it comes off the halt at 5PM EST.
They got the nod.
If it doesn't open until tomorrow, might be worth a look pre-market.

ARDX

Nov 16 (Reuters) - A panel of advisers to the U.S. Food and Drug Administration on Wednesday recommended the approval of Ardelyx Inc's(ARDX) drug for chronic kidney disease patients on dialysis.
The panel voted in favor of the drug both as a single therapy for treating high phosphate levels in the blood of chronic kidney disease patients on dialysis as well as alongside existing treatment. (Reporting by Khushi Mandowara and Leroy Leo; Editing by Krishna Chandra Eluri)

Nine_Ender · Oct 18, 2023

Nine_Ender said:
ATH new 52 week high threatening to break $1 level; MEG also hit a new 52 week high earlier.

Update since this post in June 2021 ATH has gone from under $1 to $3.30 this morning, and MEG has gone from roughly $7-8 to $28. I started trading MEG in October 2020 and ATH early 2021 ( at 0.14 a share ).